In a new study, researchers at McMaster University have identified a potential treatment for Sandhoff and Tay-Sachs ...

Meanwhile, Hims & Hers tackles the GLP-1 shortage with a new app; Eli Lilly releases data on tirzepatide efficacy; 23andMe faces privacy concerns; and more.

The financial struggles of genetic testing and ancestry company 23andMe are raising questions about the security of customers ...

Companies, 23andMe included, also have a responsibility to notify consumers of changes and get "consumers' affirmative ...

A treasure trove of genetic data may hold the key to a revolution in drug development, but it offers no clues for building a ...

even if the researchers removed those viruses’ genetic sequences from the database on which the test relies. The test still ...

NEW YORK — 23andMe is laying off 40% of its workforce, or more than 200 employees, and discontinuing its therapeutics ...

More than 200 employees of 23andMe are being laid off as part of the company’s ongoing cost-cutting measures. The layoffs ...

One investigation discussed during the call involves sales reps in China allegedly changing genetic testing results to secure reimbursement for Tagrisso.

23andMe, a popular South San Francisco-based genetic testing company, is laying off 40% of its workers after struggling with ...

Me is laying off 40% of its workforce, or more than 200 employees, and discontinuing its therapeutics division as the ...